Literature DB >> 12670538

Targeting bacterial virulence: inhibitors of type III secretion in Yersinia.

Anna M Kauppi1, Roland Nordfelth, Hanna Uvell, Hans Wolf-Watz, Mikael Elofsson.   

Abstract

Agents that target bacterial virulence without detrimental effect on bacterial growth are useful chemical probes for studies of virulence and potential candidates for drug development. Several gram-negative pathogens employ type III secretion to evade the innate immune response of the host. Screening of a chemical library with a luciferase reporter gene assay in viable Yersinia pseudotuberculosis furnished several compounds that inhibit the reporter gene signal expressed from the yopE promoter and effector protein secretion at concentrations with no or modest effect on bacterial growth. The selectivity patterns observed for inhibition of various reporter gene strains indicate that the compounds target the type III secretion machinery at different levels. Identification of this set of inhibitors illustrates the approach of utilizing cell-based assays to identify compounds that affect complex bacterial virulence systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670538     DOI: 10.1016/s1074-5521(03)00046-2

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  82 in total

1.  Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.

Authors:  Anatoly Slepenkin; Hencelyn Chu; Mikael Elofsson; Pia Keyser; Ellena M Peterson
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

2.  A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii.

Authors:  Kimberly L Carey; Nicholas J Westwood; Timothy J Mitchison; Gary E Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

3.  Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system.

Authors:  Akihiro Yamazaki; Jin Li; Quan Zeng; Devanshi Khokhani; William C Hutchins; Angela C Yost; Eulandria Biddle; Eric J Toone; Xin Chen; Ching-Hong Yang
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

Review 4.  Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

Authors:  Meghan E Feltcher; Jonathan Tabb Sullivan; Miriam Braunstein
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

5.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

6.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

7.  Novel Role for PilNO in Type IV Pilus Retraction Revealed by Alignment Subcomplex Mutations.

Authors:  Tiffany L Leighton; Neha Dayalani; Liliana M Sampaleanu; P Lynne Howell; Lori L Burrows
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

8.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  An inhibitor of gram-negative bacterial virulence protein secretion.

Authors:  Heather B Felise; Hai V Nguyen; Richard A Pfuetzner; Kathleen C Barry; Stona R Jackson; Marie-Pierre Blanc; Philip A Bronstein; Toni Kline; Samuel I Miller
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.